[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100513772":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":17,"centralContacts":22,"locations":27,"responsibleParty":44,"collaborators":46,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":57,"sex":63,"minAge":64,"maxAge":10,"enrollmentInfo":65,"targetDuration":68,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":88,"overallStatus":90,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Dysimmune manifestations with or without clonal hematopoiesis",null,[12],"Other: observational cohort study",[14],{"type":6,"name":15,"description":15,"armGroupLabels":16,"otherNames":10},"observational cohort study",[9],[18],{"name":19,"affiliation":20,"role":21},"Arsene MEKINIAN, MD PhD","Service de médecine interne, Hôpital Saint Antoine, APHP, Paris","PRINCIPAL_INVESTIGATOR",[23],{"name":19,"role":24,"phone":25,"phoneExt":10,"email":26},"CONTACT","+33149282392","arsene.mekinian@aphp.fr",[28],{"facility":29,"status":10,"city":30,"state":10,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"AP-HP, Service de médecine interne, Hôpital Saint Antoine","Paris","75012","France","FR",{"type":35,"coordinates":36},"Point",[37,38],2.3488,48.85341,{"lat":38,"lon":37},[41],{"name":42,"role":24,"phone":43,"phoneExt":10,"email":26},"Arsène MEKINIAN, MD PhD","+33 (0)1 49 28 23 92",{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[47,49,52],{"name":48,"class":6},"Sorbonne University",{"name":50,"class":51},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV",{"name":53,"class":54},"Club MINHEMON (MEDECINE INTERNE, HEMATO ET ONCO)","UNKNOWN","100513772","clonal-hematopoiesis-of-immunological-significance-100513772",false,"NCT05969821","Clonal Hematopoiesis of Immunological Significance","Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study","CHIS","Inclusion Criteria:\n\n* Age \\>=18 years old;\n* Confirmed dysimmune manifestations: clinical or biological abnormality or systemic disease;\n* Presence or absence of myeloid or lymphoid blood disease according to World Health Organization (WHO) classification\n\nExclusion Criteria:\n\n* Persons benefiting from special protection: adults under guardianship and curatorship;\n* People hospitalized without their consent and not protected by law; persons deprived of liberty;\n* Persons not affiliated to the social security system","ALL","18 Years",{"count":66,"type":67},5000,"ESTIMATED","10 Years","OBSERVATIONAL","Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.",[72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87],"Immune System Diseases","Autoimmune Diseases","Inflammation","Autoinflammatory Diseases","Vexas Syndrome","Hematopoiesis Clonal","Clonal Hematopoiesis of Indeterminate Potential","Hematologic Diseases","Myelodysplastic-Myeloproliferative Diseases","Leukemia Myelomonocytic Chronic","Myelodysplastic Syndromes","Myeloproliferative Disorders","Lymphoproliferative Disorders","Lymphoma","Leukemia","Monoclonal Gammopathy of Undetermined Significance",[74,75,89,73,78,80,84,87],"Vexas syndrome","NOT_YET_RECRUITING","2026-03-19",{"date":93,"type":94},"2026-03-23","ACTUAL",{"date":96,"type":67},"2026-04",{"date":98,"type":67},"2045-09",{"name":5,"class":6},1]